<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 06 Mar 2026 17:51:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26126909.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26126909.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26126909.html</guid>
   <pubDate>Fri, 06 Mar 2026 17:51:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26126909.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26126909.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26126909.html</guid>
   <pubDate>Fri, 06 Mar 2026 17:51:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26126905.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26126905.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26126905.html</guid>
   <pubDate>Fri, 06 Mar 2026 17:50:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26126905.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26126905.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26126905.html</guid>
   <pubDate>Fri, 06 Mar 2026 17:50:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  424B7      Protara Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B7++++++Protara+Therapeutics%2C++++++++++++++++/26125645.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26125645.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B7++++++Protara+Therapeutics%2C++++++++++++++++/26125645.html</guid>
   <pubDate>Fri, 06 Mar 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  424B7      Protara Therapeutics,                </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++424B7++++++Protara+Therapeutics%2C++++++++++++++++/26125645.html</link>
   <description>si-local-file:///var/storage/secattach/20260306/26125645.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++424B7++++++Protara+Therapeutics%2C++++++++++++++++/26125645.html</guid>
   <pubDate>Fri, 06 Mar 2026 16:15:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26113646.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26113646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26113646.html</guid>
   <pubDate>Wed, 04 Mar 2026 20:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26113646.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26113646.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26113646.html</guid>
   <pubDate>Wed, 04 Mar 2026 20:37:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26113643.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26113643.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26113643.html</guid>
   <pubDate>Wed, 04 Mar 2026 20:35:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26113643.html</link>
   <description>si-local-file:///var/storage/secattach/20260304/26113643.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26113643.html</guid>
   <pubDate>Wed, 04 Mar 2026 20:35:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Protera Therapeutics (TARA) at Overweight</title>
   <link>http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Protera+Therapeutics+%28TARA%29+at+Overweight/26105975.html</link>
   <description>&lt;p&gt;JPMorgan analyst Brian Cheng initiates coverage on Protara Therapeutics (NASDAQ: TARA) with a Overweight rating and a price target of $27.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;TARA is advancing TARA-002, a lyophilized heat- and penicillin-killed preparation of Strep pyogenes in non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). As the replica of approved picibanil in Japan/Taiwan, we believe '002 is highly de-risked based on the clinical experience picibanil has collected in the target indications. Particularly in NMIBC, we believe TARA-002 holds a balanced profile that resembles much of the gold standard BCG that's in constant supply shortage. The recent weakness following the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Protera+Therapeutics+%28TARA%29+at+Overweight/26105975.html</guid>
   <pubDate>Wed, 04 Mar 2026 03:03:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Protera Therapeutics (TARA) at Overweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Protera+Therapeutics+%28TARA%29+at+Overweight/26105975.html</link>
   <description>&lt;p&gt;JPMorgan analyst Brian Cheng initiates coverage on Protara Therapeutics (NASDAQ: TARA) with a Overweight rating and a price target of $27.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;TARA is advancing TARA-002, a lyophilized heat- and penicillin-killed preparation of Strep pyogenes in non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). As the replica of approved picibanil in Japan/Taiwan, we believe '002 is highly de-risked based on the clinical experience picibanil has collected in the target indications. Particularly in NMIBC, we believe TARA-002 holds a balanced profile that resembles much of the gold standard BCG that's in constant supply shortage. The recent weakness following the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Protera+Therapeutics+%28TARA%29+at+Overweight/26105975.html</guid>
   <pubDate>Wed, 04 Mar 2026 03:03:58 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Protara Therapeutics (TARA) at Overweight</title>
   <link>http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Protara+Therapeutics+%28TARA%29+at+Overweight/26105976.html</link>
   <description>&lt;p&gt;JPMorgan analyst Brian Cheng initiates coverage on Protara Therapeutics (NASDAQ: TARA) with a Overweight rating and a price target of $27.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;TARA is advancing TARA-002, a lyophilized heat- and penicillin-killed preparation of Strep pyogenes in non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). As the replica of approved picibanil in Japan/Taiwan, we believe '002 is highly de-risked based on the clinical experience picibanil has collected in the target indications. Particularly in NMIBC, we believe TARA-002 holds a balanced profile that resembles much of the gold standard BCG that's in constant supply shortage. The recent weakness following the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/JPMorgan+Starts+Protara+Therapeutics+%28TARA%29+at+Overweight/26105976.html</guid>
   <pubDate>Wed, 04 Mar 2026 03:03:50 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>JPMorgan Starts Protara Therapeutics (TARA) at Overweight</title>
   <link>http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Protara+Therapeutics+%28TARA%29+at+Overweight/26105976.html</link>
   <description>&lt;p&gt;JPMorgan analyst Brian Cheng initiates coverage on Protara Therapeutics (NASDAQ: TARA) with a Overweight rating and a price target of $27.00.&lt;/p&gt;&lt;p&gt;The analyst comments: &quot;TARA is advancing TARA-002, a lyophilized heat- and penicillin-killed preparation of Strep pyogenes in non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). As the replica of approved picibanil in Japan/Taiwan, we believe '002 is highly de-risked based on the clinical experience picibanil has collected in the target indications. Particularly in NMIBC, we believe TARA-002 holds a balanced profile that resembles much of the gold standard BCG that's in constant supply shortage. The recent weakness following the</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/JPMorgan+Starts+Protara+Therapeutics+%28TARA%29+at+Overweight/26105976.html</guid>
   <pubDate>Wed, 04 Mar 2026 03:03:50 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Protara Therapeutics,                  Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26092474.html</link>
   <description>si-local-file:///var/storage/secattach/20260302/26092474.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26092474.html</guid>
   <pubDate>Mon, 02 Mar 2026 16:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Protara Therapeutics,                  Filed by: MILLENNIUM MANAGEMENT LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26092474.html</link>
   <description>si-local-file:///var/storage/secattach/20260302/26092474.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+MILLENNIUM+MANAGEMENT+LLC/26092474.html</guid>
   <pubDate>Mon, 02 Mar 2026 16:20:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26062237.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26062237.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26062237.html</guid>
   <pubDate>Wed, 25 Feb 2026 19:58:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26062237.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26062237.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26062237.html</guid>
   <pubDate>Wed, 25 Feb 2026 19:58:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26062234.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26062234.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26062234.html</guid>
   <pubDate>Wed, 25 Feb 2026 19:57:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26062234.html</link>
   <description>si-local-file:///var/storage/secattach/20260225/26062234.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26062234.html</guid>
   <pubDate>Wed, 25 Feb 2026 19:57:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26053944.html</link>
   <description>si-local-file:///var/storage/secattach/20260224/26053944.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26053944.html</guid>
   <pubDate>Tue, 24 Feb 2026 21:14:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: 667, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26053944.html</link>
   <description>si-local-file:///var/storage/secattach/20260224/26053944.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+667%2C+L.P./26053944.html</guid>
   <pubDate>Tue, 24 Feb 2026 21:14:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26053933.html</link>
   <description>si-local-file:///var/storage/secattach/20260224/26053933.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26053933.html</guid>
   <pubDate>Tue, 24 Feb 2026 21:11:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  144        Protara Therapeutics,                  Filed by: Baker Brothers Life Sciences LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26053933.html</link>
   <description>si-local-file:///var/storage/secattach/20260224/26053933.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Protara+Therapeutics%2C++++++++++++++++++Filed+by%3A+Baker+Brothers+Life+Sciences+LP/26053933.html</guid>
   <pubDate>Tue, 24 Feb 2026 21:11:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
  <item>
   <title>Form  8-K        Protara Therapeutics,     For: Feb 23</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protara+Therapeutics%2C+++++For%3A+Feb+23/26047596.html</link>
   <description>si-local-file:///var/storage/secattach/20260224/26047596.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Protara+Therapeutics%2C+++++For%3A+Feb+23/26047596.html</guid>
   <pubDate>Tue, 24 Feb 2026 08:53:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02411061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TARA</category>
   	  </item>
 </channel>
</rss>
